|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 211/46 | (2006.01) |
| C07D 211/46 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 31/445 | (2006.01) |
| (11) | Number of the document | 4114826 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21798287.5 |
| Date of filing the European patent application | 2021-10-01 | |
| (97) | Date of publication of the European application | 2023-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2021/077100 |
| Date | 2021-10-01 |
| (87) | Number | WO 2022/069709 |
| Date | 2022-04-07 |
| (30) | Number | Date | Country code |
| 20199934 | 2020-10-02 | EP |
| (72) |
HETT, Robert , NL
BLATTER, Fritz , NL
ROBIN, Jennifer , NL
LANDSKRONER, Kyle , CH
|
| (73) |
Azafaros B.V. ,
J.H. Oortweg 21, 2333 CH Leiden,
NL
|
| (54) | CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND |
| CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND |